# EnVivo Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/envivo-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.envivopharma.com
- Total disclosed funding: $43M
- Latest round: Series C (Sep 26, 2006)
- Investors on record: 6

## About

EnVivo Pharmaceuticals Inc. is a US-based company that operates as a developer of small molecule therapeutics for the disorders of the central nervous system.

## Funding rounds

- Series C, Sep 26, 2006, $12M — F-Prime Capital
- Series B, Sep 20, 2004, $16M — F-Prime Capital, BCM Technologies
- Series A, Oct 1, 2002, $15M — Baylor College of Medicine Endowment, Cogene Ventures, BCM Ventures, F-Prime Capital, BioTex Finance

## Investors

- Baylor College of Medicine Endowment — Series A
- Cogene Ventures (https://capitalatlas.ai/funds/cogene-ventures) — Series A
- BCM Ventures (https://capitalatlas.ai/funds/bcm-ventures) — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B, Series C
- BioTex Finance — Series A
- BCM Technologies — Series B